Form 4 Tracker
Axsome Therapeutics, Inc.
AXSM

34 insider filings · Latest: Aug 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 13, 2025Feb 13 9:02 PMPizzie Nick
Proposed Sale
12,000$129.86$1.6M

View →

Sep 11, 2024Sep 11 8:32 PMSaad Mark E
Proposed Sale
11,016$91.31$1.0M

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 21, 2026Apr 24 1:00 AMHunter R. MurdockGeneral Counsel
Grant/Award
7,2247,224(D)

View →

Feb 26, 2026Feb 28 12:10 AMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Grant/Award
54,62354,623(D)

View →

Feb 26, 2026Feb 28 12:10 AMNick PizzieChief Financial Officer
Grant/Award
18,57018,570(D)

View →

Feb 26, 2026Feb 28 12:10 AMHunter R. MurdockGeneral Counsel
Grant/Award
16,38516,385(D)

View →

Feb 26, 2026Feb 28 12:10 AMAri MaizelChief Commercial Officer
Grant/Award
16,38516,385(D)

View →

Feb 26, 2026Feb 28 12:10 AMMark L. JacobsonChief Operating Officer
Grant/Award
19,66319,663(D)

View →

Feb 26, 2026Feb 28 12:00 AMMark L. JacobsonChief Operating Officer
Option Exercise
35,378$2.850(D)

View →

Feb 23, 2026Feb 26 12:00 AMMark ColemanDirector
Option Exercise
6,250$4.957,721(D)

View →

Feb 20, 2026Feb 24 12:23 AMMark ColemanDirector
Option Exercise
12,485$4.9513,971(D)

View →

Feb 10, 2026Feb 11 12:11 AMMark ColemanDirector
Option Exercise
5,193$8.020(D)

View →

Feb 2, 2026Feb 2 11:30 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
32,410$185.600(D)

View →

Jan 22, 2026Jan 24 12:00 AMNick PizzieChief Financial Officer
Option Exercise
12,000$3.50105,000(D)

View →

Jan 21, 2026Jan 24 12:00 AMAri MaizelChief Commercial Officer
Option Exercise
7,500$70.7331,210(D)

View →

← Previous

Page 2 of 2